There have been no new therapies for genital herpes in 20 years. GEN-003 has consistently and safely improved several important genital herpes disease parameters in clinical studies.
Genocea understands that cancer is personal. We are leveraging our ATLAS platform to identify new targets that are specific to each individual. Our expertise in vaccinology enables us to turn those targets to personalized cancer vaccines.